{"name":"Grindeks","slug":"grindex","ticker":"GRD1R","exchange":"NASDAQ Riga (RG)","domain":"grindeks.lv","description":"JSC Grindex, or simply Grindeks, is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021, Grindex exported products to more than 90 countries.","hq":"Riga, Latvia","founded":0,"employees":"","ceo":"Juris Bundulis","sector":"Generics / API Manufacturing","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$85M","metrics":{"revenue":230000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Losartan patent cliff ($1.2B at risk)","drug":"Losartan","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Amlodipine patent cliff ($1.5B at risk)","drug":"Amlodipine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Grindeks Reports Strong Q4 2023 Earnings","summary":"Grindeks announced its Q4 2023 earnings, reporting a significant increase in revenue and profitability.","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"deal","headline":"Grindeks Partners with Local Distributor for Expanded Reach","summary":"Grindeks announced a partnership with a local distributor to expand its reach in the European market.","drugName":"","sentiment":"neutral"}],"realNews":[],"patents":[{"drugName":"Losartan","drugSlug":"losartan-potassium","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Amlodipine","drugSlug":"amlodipine-besylate","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":1500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sandoz","Stada","Teva"],"therapeuticFocus":["Cardiovascular","Central Nervous System","Respiratory"],"financials":null,"yahoo":null}